Leila R. Jirari, PA

Leila Jirari practices at Marshall Medical in Placerville, California, part of Marshall Medical Center.

Leila Jirari's NPI, 1720337587, was assigned on September 7, 2012. Leila Jirari holds California license PA22352.

Leila Jirari's primary practice is Marshall Medical, at 1100 Marshall Way, Placerville, CA 95667 in El Dorado County. The practice phone is (530) 622-1441.

Leila Jirari's primary practice is Marshall Medical in Placerville, California, part of Marshall Medical Center. Leila Jirari is also affiliated with Tahoe Forest Hospital. The medical group on file is Vituity. Dmand AI also links Leila Jirari to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Leila Jirari practices, 2 sites in all. Vendor and product names are available with a free account.

Medical is Leila Jirari's primary specialty in the NPI Registry, under taxonomy code 363AM0700X. Leila Jirari is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Leila Jirari is licensed in California.

Dmand AI lists acute sinusitis, alcohol use disorders, drug use disorders, fibromyalgia and chronic pain, thoracic spine disorders and tobacco use among the conditions Leila Jirari treats.

CMS data shows 132 Medicare services from Leila Jirari across 4 procedure codes in 2024, for 129 Medicare patients. Medicare paid $11,330 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 129 Medicare patients who saw Leila Jirari in 2024. The largest group is 65 to 74, with 56 patients. 74% of them have high cholesterol, and 67% have high blood pressure. 35% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Leila Jirari's median patient age at 57, with 52% women.

In 2024, Leila Jirari wrote 350 Medicare Part D claims for 91 patients. 85% of them were for generic drugs. CMS names the drug for 209 of them, across 11 drugs with 11 or more claims each, at $44,700 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Leila Jirari for performance year 2024, reported as part of a group. Leila Jirari accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 43 general payments to Leila Jirari from 12 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $170.